Skip to main content

CCL15/MIP-1 delta Antibody (124) [PE]

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-89704PE

Recombinant Monoclonal Antibody
Novus Biologicals, part of Bio-Techne

Key Product Details

Species Reactivity

Human

Applications

Sandwich ELISA Capture

Label

PE (Excitation = 488 nm, Emission = 575 nm)

Antibody Source

Recombinant Monoclonal Rabbit IgG Clone # 124

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

This antibody was obtained from a rabbit immunized with purified, recombinant Human CCL15/MIP-1 delta (Uniprot#: Q16663-1; Gln22-Ile113).

Clonality

Monoclonal

Host

Rabbit

Isotype

IgG

Applications for CCL15/MIP-1 delta Antibody (124) [PE]

Application
Recommended Usage

Sandwich ELISA Capture

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Protein A purified

Formulation

PBS

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: CCL15/MIP-1 delta

CCL15 - chemokine (C-C motif) ligand 15

Alternate Names

HCC-2, Leukotactin 1, MIP-1 delta, MIP-5, MIP1 delta, NCC-3

Gene Symbol

CCL15

Additional CCL15/MIP-1 delta Products

Product Documents for CCL15/MIP-1 delta Antibody (124) [PE]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for CCL15/MIP-1 delta Antibody (124) [PE]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...